Healthcare specialist SHS Capital has raised about €270 million, closing its fund oversubscribed from the initial target of €200 million. The SHS VI fund invests in growing European healthcare companies that have already reached high revenues and are setting their sights on becoming ‘European healthcare campions’.
The SHSVI fund is aiming to fulfil ten to fifteen investments of €10 to €40 million in the form of both majority and minority positions and transaction values up to €150 million together with LPs and other investors.
"The healthcare sector is an indispensable sector and therefore offers numerous exciting opportunities for investments. With us, investors have the chance to participate in the development of this growth market. Our track record shows attractive returns for our investors and at the same time contribute to improving the healthcare system through innovations and optimising patient care,” says Manfred Ulmer-Weber, Managing Partner at SHS.
Amongst the investors of SHS VI are fund of funds, insurance companies, pension funds, foundations, family offices, banks, healthcare corporates, church investors, and entrepreneurs, with the SHS investment team itself investing significantly.
"The volume of the new fund has significantly exceeded our expectations and confirmed our positioning as the leading private equity healthcare specialist in Germany, and thus the largest European healthcare market. We are very pleased that many of SHS’s investors in previous funds have also invested in our new fund, in some cases with significantly increased subscriptions. In addition, we were able to further internationalize our pool of investors and expand it with renowned addresses. We would like to thank our investors for their trust," says SHS Managing Partner Sascha Alilovic.
Lead image via SHS Capital. Photo: Uncredited.